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Substantial evidence in medical literature indicates a relationship
between the prognosis of invasive ductal breast cancer and the
degree of histological differentiation (Roberts and Hahnel, 1981;
Tosi et al, 1986; Clayton, 1991; Lipponen et al, 1991; Fisher et al,
1993; Garne et al, 1994). Evaluation of the degree of tubular
differentiation in the tumour tissue is part of histological malig-
nancy grading of invasive breast cancer (Patey and Scarff, 1928;
Bloom and Richardson, 1957; WHO, 1981). The assessment of
tubular differentiation in breast cancer grading has, however, often
been accused of inaccuracy and poor reproducibility. Therefore the
contribution of the assessment of tubular differentiation to breast
cancer prognostication and treatment decisions may be underesti-
mated.
Previously, we have introduced numerical thresholds for
nuclear grade and mitotic activity in breast cancer based on
follow-up information (Kronqvist et al, 1998a, 1998b). The
thresholds were part of the development of the morphometric
grading system which we are designing for invasive ductal breast
cancer. We have now set out to determine corresponding thresh-
olds for tubular differentiation. The final aim is to augment the
prognostic potential and improve the reproducibility of breast
cancer grading with the help of quantitative histological
methods.
Materials and methods
Patients
The study comprises 172 cases of invasive ductal breast cancer
diagnosed and treated at Turku University Hospital in the years
1989–1991 (Table 1). Complete follow-up histories and periopera-
tive specimens from the primary tumours were available for all
patients. The patients with previously detected breast cancer in
unilateral or contralateral breast were excluded from the material.
Moreover, we left out of the analysis all cases of M1 stage if the
distant metastasis was detected within 1 month of diagnosis.
Metastases were detected by routine chest and bone radiographs,
laboratory test reflecting bone and liver metabolism and by cyto-
logical and histological samples when obtainable. All patients were
treated by radical or modified radical mastectomy with axillary
evacuation. None of the patients received preoperative radiation
therapy or other preoperative adjuvant treatments. Two different
post-operative adjuvant treatment protocols were applied in our
hospital during the follow-up period of our breast cancer material.
At the end of the 1980s, anti-oestrogen (post-menopausal patients)
and cytostatic (premenopausal) therapy was given to all patients
with T4 stage disease. Patients with histologically verified metas-
tasis in four or more axillary lymph nodes or in one apical lymph
node received the same treatment. At the beginning of the 1990s,
anti-oestrogen treatment or cytostatic drugs were given to all
patients with histologically verified axillary lymph node metastases.
In our material post-operative early adjuvant systemic therapy was
given to 50 patients, 36 of whom received endocrine therapy and 14
chemotherapy. The causes of death were collected from autopsy
reports, death certificates and patient files. The overall survival rate
was 67.4% and breast cancer-related survival rate was 73.4% as
determined at 5 years of follow-up by excluding patients dead of
causes other than breast carcinoma.
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The histological samples used in assessments of tubular differenti-
ation were fixed in buffered formalin (pH 7.0), embedded in
paraffin, sectioned at 5 mm and stained with haematoxylin and
eosin.
To begin with the tubular measurements we chose the most
representative slide of each case, placing special emphasis on the
quality of the histological details. Tubular differentiation was
evaluated in each sample as the fraction of fields showing tubular
differentiation (FTD) (Kronqvist et al, 1999). According to this
method tubular differentiation was assessed in the whole tumour
area. The sample was screened field by field with ´25 magnifica-
tion (field diameter 710 mm) and the presence or absence of malig-
nant tubular structures in each microscopic field was registered.
By this method the field was registered positive if a single
undoubtable malignant tubular structure was identified. The final
result was the fraction of fields presenting tubular differentiation.
This assessment method has been developed in our research group
and is especially recommended because it has turned out to be the
most efficient and fastest way to evaluate in quantitative terms the
tubular differentiation in invasive breast cancer. In a previous
paper comparing several evaluation methods for tubular differenti-
ation (Kronqvist et al, 1999), FTD showed out to be the most
practical, accurate and reproducible way to determine tubular
differentiation in invasive ductal breast cancer.
In the evaluations, special emphasis was placed on histological
identification of the malignant tubuli. The main criteria for regis-
tering a tubulus was a definite lumen within a tubular or alveolar
structure created by surrounding malignant epithelial cells. Special
consideration was taken not to mistake adipocytes, central necrosis
or clefts due to shrinkage artifacts as tubular spaces. Luminal
structures in cribriform malignant epithelium were not counted
either.
Statistical analysis
The results were analysed with the SAS statistical package (SAS®
System for Windows™ release 6.12, SAS Institute Inc., Cary, NC,
USA) in the whole patient material, and in subgroups of samples
divided by the patients’ age and axillary lymph node status at
diagnosis and tumour size. The prognostic value of all possible
cutpoints for FTD was tested throughout their range to find the
optimal threshold for tubular differentiation. The prognostic value
of the tested cut-offs was estimated on the basis of outcome in
patient groups with FTD below and above the cut-off. For this
purpose Kaplan–Meier curves (Cutler and Ederer, 1958) were
drawn for each cut-off based on survival of disease and disease-
free period, and the curves were tested for statistical significance
with the help of log-rank test (P-values and c2 values). The c2 of
log-rank tests were summarized in diagrams showing the variation
of statistical significance associated with each tested cut-off. The
cut-off resulting in the clearest rise in statistical significance was
considered to best stratify the cases with different prognosis of
disease and represent the most reliable thresholds for classification
of patients on the basis of FTD. The false-positive rate of the
minimum P-value approach was taken into account and the
corrected  P-value (Pcor) calculated as suggested by Altman and co-
workers (e = 0.1) (Altman et al, 1994). Univariate and multivariate
analyses based on Cox’s regression were applied to evaluate the
prognostic significance of tubular differentiation. Associations
between different prognostic factors and breast cancer outcome
were quantified with ratios indicating relative risk (RR) of breast
cancer recurrence or death and the corresponding 95% confidence
intervals (95% CI).
The threshold and the confidence associated with the classifica-
tion by the threshold was determined with the help of grading effi-
ciencies (GE) (Galen and Gambino, 1975; Collan, 1989; Collan et
al, 1992) and Receiver Operating Characteristic (ROC) curves
(Hanley and McNeil, 1982; Beck and Schultz, 1986; Zweig and
Campbell, 1993; Kairisto and Poola, 1995). The efficiencies and
the ROC curves were produced with the help of the GraphROC
software (GraphROC for Windows, University of Turku,
Department of Clinical Chemistry, Turku, Finland) (Kairisto and
Poola, 1995) and they represent the potential of the method to
distinguish live patients from those dead from breast cancer at
5 years of follow-up.
RESULTS
The mean fraction of FTD in our material was 30.0% (median
22.2%, standard deviation 28.2%). When applying the established
thresholds of subjective tubular grading (10% and 75% of tumour
area showing tubule formation)22,23 to our results of FTD, 9.3% of
the cases indicated favourable, 54.7% intermediate and 36.0%
unfavourable prognosis of disease.
Figure 1 demonstrates the distribution of chi-values of log-rank
tests associated with all the possible cut-offs of FTD determined at
1% intervals. The peak in statistical significance (P = 0.0026, Pcor
= 0.0215) at FTD 59% was considered to represent the most
reliable threshold (FTD59%) for classifying patients according to
tubular differentiation. Moreover, we observed a smaller but still
statistically significant peak at FTD 23% (threshold FTD23%).
Figure 2 demonstrates the potential of the determined thresholds
to stratify between patients with favourable, intermediate and
unfavourable outcome of disease. The thresholds FTD59% and
FTD23% were identical in analyses based on breast cancer survival
and on disease-free period in the whole material. Both thresholds
could be detected also in analyses of post-menopausal patients
(Table 2). In most prognostic subgroups, however, only FTD59%
could be verified as a threshold. FTD23%, in turn, was detected as
the only threshold among axillary lymph node-positive patients.
No statistically significant threshold could be found among cases
of small tumour size (equal to or below 2 cm in diameter).
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Table 1 Characteristics of the patients (n = 172)
Mean age at diagnosis (range) 59.1 years (32.6–86.5 years)
Menopausal status
No. of premenopausal women 56 (32.6%)
No. of post-menopausal women 116 (67.4%)
Axillary lymph node status
No. of positive patients 72 (41.9%)
No. of negative patients 100 (58.1%)
Mean tumour size (range) 2.9 cm (0.6–15.0 cm)
Mean follow-up time (range) 5 years 8 months (5 months –
8 years 11 months)
No. of cases with recurrence 66 (38.4%)
Causes of death during follow-up
Breast cancer 42 (24.4%)
Other cancer 5 (2.9%)
Other 9 (5.2%)1658 P Kronqvist et al
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Table 3 summarizes the relative risks (RRs) of univariate
analyses describing the risk of breast cancer death associated with
feature values below the thresholds as compared with feature
values above the thresholds. In results of the whole material,
FTD59% was the most powerful predictor of survival with a 6.7-fold
risk of breast cancer death. FTD23% was associated with a 1.9-fold
risk of breast cancer death. Among axillary lymph node-positive
patients, however, FTD23% was the strongest significant prognosti-
cator for survival.
In multivariate analysis of the whole material among FTD59%,
menopausal status and axillary lymph node status at diagnosis
(Table 4), FTD59% was associated with a 6.3-fold risk of breast
cancer death. Axillary lymph node status was verified as an
independent prognostic factor in the whole material, among post-
menopausal patients and patients with small tumour size (tumour
diameter equal to or below 2 cm).
The grading efficiencies of FTD59% and FTD23% at 5 years
follow-up were determined with the help of ROC-analysis. The
GEs of the cut-offs of subjective evaluation of tubular differentia-
tion in the SBR classification (Ellis and Elston, 1991; Simpson and
Page, 1994) (0.588 and 0.563 for the cut-offs of 10% and 75%
respectively) were inferior to the FTD-based morphometric thresh-
olds (0.620 and 0.591 for FTD59% and FTD23% respectively). The
area under curve (AUC) of ROC analysis in the whole material is
0.611, indicating moderate classification potential of the method.
The maximum efficiency point of ROC analysis in the whole
material at 58.4% supports the conclusion of FTD59% as the
optimal threshold for tubular grading. Among node-positive cases
the maximum efficiency point at 22.2% corresponds to the
threshold FTD23%.
DISCUSSION
Based on follow-up information of breast cancer survival and
recurrence the optimal (minimum P-value) threshold for tubular
differentiation could be determined at TDF 59%. The practical
interpretation is that tubular differentiation observed in at least
60% of the microscopical fields in the tumour area indicates
favourable prognosis of disease. FTD59% is relevant also for prog-
nostication in pre- and post-menopausal and axillary lymph node
negative subgroups of patients as well as in cases of large tumour
size (diameter above 2 cm). Another threshold detected at FTD
23% was efficient especially in predicting the prognosis of axillary
lymph node-positive patients. This threshold could be applied in
identifying those patients with the worst outcome of disease.
In medical literature, the ‘minimum P-value approach’ has been
considered contradictory (Altman et al, 1994) which suggests that
the results of this type of statistical analysis should be interpreted
cautiously. In the present study, however, the reliability of the
results is emphasized by the fact that the same numerical thresh-
olds for tubular differentiation could also be found in univariate
and multivariate analysis of Cox’s regression, and in ROC-
analysis based on the follow-up information of the patient mate-
rial. The relative risks for breast cancer death associated with
FTD59% were 6.7- and 6.3-fold in univariate and multivariate
analyses respectively. Concluding from Kaplan–Meier curves of
breast cancer survival the determined thresholds for tubular differ-
entiation very efficiently stratified the patients with different
outcome of disease, especially in favourable and intermediate
prognostic groups (threshold FTD59%).
In light of previous medical literature the prognostic value of
tubular differentiation in invasive breast cancer is conflicting.
Many papers report that tubular differentiation is a noteworthy
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Figure 1 The distribution of X2 of log-rank tests associated with the cut-offs
for the fraction of tubular differentiation (FTD) in 172 cases of invasive breast
cancer. The cut-off with the clearest rise in statistical significance at FTD 59%
was considered to represent the most reliable thresholds for classification of
patients on the basis of survival and recurrence of disease. Another peak
showing lower but still statistically significant chi-square values was found at
FTD 23%
Figure 2 The determined threshold, FTD59%, for tubular differentiation
clearly stratify the patients with favourable (A) and intermediate (B) prognosis
(P = 0.009). The threshold FTD23% could be applied to distinguish those
patients with the worst outcome of disease (C) (P = 0.041)
Table 2 Thresholds for FTD determined on the basis of follow-up
information on breast cancer survival of 172 breast cancer patients
Group of patients Lower threshold Higher threshold
ALL 23% 59%
Premenopausal 59%
Postmenopausal 23% 59%
Tumour diameter < 2 cm
Tumour diameter ³ 2 cm 59%
Node – 59%
Node + 23%
All = all patients. Node – = axillary lymph node-negative patients. Node + =
axillary lymph node-positive patients.
The table includes results of analyses in the whole material and in prognostic
subgroups stratified according to menopausal and axillary lymph node status
at diagnosis, and tumour size. The thresholds shown divide the patient
material into two groups the survival of which is different at a significance
level of P < 0.05. When several significant cutpoints were found the threshold
showing the lowest P-value was chosen.Thresholds for tubular grading 1659
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Table 3 Univariate analyses performed in the whole material of 172 patients on the determined thresholds for
fraction of tubular differentiation, FTD59% and FTD23%, and the patients’ menopausal status, axillary lymph node
status and tumour size
Group of patients Feature P RR 95% Cl
ALL FTD59% 0.009 6.7 1.7–27.8
Nodal status 0.002 2.7 1.5–5.1
FTD23% 0.041 1.9 1.0–3.6
Tumour size 0.164 1.5 0.8–2.9
Menopausal status 0.470 0.8 0.4–1.5
Premenopausal FTD59% 0.072 6.4 0.8–48.4
Nodal status 0.055 2.6 1.0–7.1
Tumour size 0.254 1.9 0.6–5.3
FTD23% 0.992 1.0 0.4–2.7
Post-menopausal FTD23% 0.011 3.3 1.3–8.2
Nodal status 0.010 2.9 1.3–6.5
FTD59% 0.054 7.1 1.0–52.6
Tumour size 0.417 1.4 0.6–3.0
Tumour diameter ≤ 2c m Nodal status 0.021 3.0 1.2–7.4
FTD23% 0.182 1.7 0.3–4.0
Menopausal status 0.447 0.7 0.3–1.6
FTD59% 0.991 NS NS
Tumour diameter > 2 cm FTD59% 0.172 2.8 0.6–12.3
FTD23% 0.132 2.2 0.8–5.9
Nodal status 0.105 2.2 0.8–5.8
Menopausal status 0.994 1.0 0.4–2.8
Node – FTD23% 0.765 1.2 0.4–3.1
Tumour size 0.977 1.0 0.4–2.7
Menopausal status 0.488 0.7 0.3–1.9
FTD59% 0.992 NS NS
Node + FTD23% 0.035 2.6 1.1–6.1
FTD59% 0.115 3.2 0.8–13.5
Tumour size 0.529 1.3 0.6–3.1
Menopausal status 0.564 0.8 0.4–1.8
ALL = all patients. Node – = axillary lymph node-negative patients. Node + = axillary lymph node-positive patients.
In addition to the P values, risk ratios (RR) of breast cancer death with 95% confidence intervals (95% Cl) in the
whole material and in the prognostic subgroups are shown. RRs are presented in size order and the level of
statistical significance is indicated (P < 0.05 in bold, 0.1 < P < 0.05 in italics).
Table 4 Multivariate analyses performed in the whole material of 172 patients on the determined thresholds for fraction of tubular differentiation, FTD59% and
FTD23%, and the patients’ menopausal status, and axillary lymph node status.
Group of patients Feature P RR 95% Cl
ALLa FTD59% 0.011 6.3 1.5–26.2
Nodal status 0.003 2.6 1.4–4.8
Menopausal status 0.285 0.7 0.4–1.3
Nodal status 0.002 2.7 1.4–5.0
FTD23% 0.051 1.9 1.0–3.5
Menopausal status 0.296 0.7 0.4–1.3
Feature with the highest RR
Analysis including FTD59%
Premenopausala Tub59% 0.101 5.5 0.7–42.1
Post-menopausala Tub59% 0.052 7.3 1.0–53.7
Tumour diameter ≤ 2c m b Nodal status 0.015 3.2 1.3–8.0
Tumour diameter > 2 cmb Tub59% 0.211 2.6 0.6–11.8
Node –c Menopausal status 0.263 0.6 0.2–1.5
Node +c Tub59% 0.119 3.2 0.7–13.4
Analysis including FTD23%
Premenopausala Nodal status 0.055 2.6 1.0–7.1
Post-menopausala FTD23% 0.013 3.2 1.3–8.0
Tumour diameter ≤ 2c m b Nodal status 0.020 3.0 1.2–7.6
Tumour diameter > 2 cmb Nodal status 0.087 2.3 0.9–6.1
Node –c FTD23% 0.725 1.2 0.4–3.2
Node +c FTD23% 0.033 2.6 1.1–6.1
ALL = all patients, Node2 = axillary lymph node-negative patients, Node+ = axillary lymph node-positive patients. aAdjusted for axillary lymph node status and
tumour size. bAdjusted for axillary lymph node status. cAdjusted for tumour size. In addition to the P values, risk ratios (RR) of breast cancer death with 95%
confidence intervals (95% Cl) in the whole material and in the prognostic subgroups are shown. RRs are presented in size order and the level of statistical
significance is indicated (P<0.05 in bold, 0.1<P<0.05 in italics).prognosticator of breast cancer outcome (Fisher et al, 1975, 1984;
Parl and Dupont, 1982; Davis et al, 1986; Fisher, 1986; Theissig et
al, 1990; Dalton et al, 1994; Robbins et al, 1995). On the other
hand, there is an abundance of papers stating that tubular differen-
tiation lacks prognostic significancy and is inferior to the other
two features of histological breast cancer grading (Black et al,
1955; Baak et al, 1985; Rank et al, 1987; Le Doussal et al, 1989;
van der Linden et al, 1989; Theissig et al, 1990; Clayton, 1991;
Lipponen et al, 1991; Parham et al, 1992; Schumacher et al, 1993;
Dalton et al, 1994). In our opinion, these contradictions reflect the
subjectivity of the evaluation methods rather than the lack of
biological significance of tubular differentiation. Neither the tradi-
tional (Patey and Scarff, 1928; Bloom and Richardson, 1957) nor
the modified grading systems of breast cancer (WHO, 1981;
Haybittle et al, 1982; Todd et al, 1987; Ellis and Elston, 1991;
Simpson and Page, 1994) give detailed guidelines for identifica-
tion of tubular structures or numerical quantification of the degree
of tubular differentiation in the tumour tissue. In the present study
tubular differentiation was registered as fraction of fields with
tubular differentiation (FTD) (Kronqvist et al, 2000). The method
has been developed in our research group and proven accurate,
reliable and practical. One advantage of the method is that the
assessment is performed field by field which directly results in a
numerical estimate of tubular differentiation in the tumour area.
Because in each field only the presence or absence of clearly
defined tubuli is registered, the method is unambiguous, simple
and relatively fast so that even a large section can be screened in
fewer than 10 min. The obvious disadvantage of our method is,
however, that the FTD is not directly comparable with the tradi-
tional subjective assessment method.
Our final aim is to adapt the results of the threshold analyses
of tubular differentiation to the histological grading of invasive
ductal breast cancer (Patey and Scarff, 1928; Bloom and
Richardson, 1957; WHO, 1981). In order to maintain the tradi-
tional three-score system two alternative policies can, in our view-
point, be followed. For the first, the two most efficient thresholds
for tubular differentiation, FTD59% and FTD23%, can be applied in
the grading system, although the prognostic contribution of
FTD23% can be expected to be weak in many patient groups.
Secondly, the scoring of the breast cancer grading system can be
reorganized to apply only one threshold for tubular differentiation
at FTD 59% (Table 5). This would result in a grading system with
a total of 8 points which would equalize the score groups and
simplify the allocation of the scores into their respective grades.
In light of our results tubular differentiation is an independent
prognostic factor of invasive breast cancer. It is commonly
believed that the prognostic value of histologically assessed
tubular differentiation is presumably inferior to those of nuclear
grade and mitotic activity. Future studies will show what are the
prognostic contributions of the assessment of tubular differentia-
tion in morphometric grading of invasive breast cancer (Kronqvist
et al, 1998a, 1998b). The present study supports the application of
the traditional three-subfeature grading system of invasive ductal
breast cancer. Previous experiences together with our results
suggest that tubular differentiation as evaluated by FTD could also
be applicable in future automatic grading systems (Dufer et al,
1993).
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